Published in J Exp Med on June 01, 1987
Expression of Wnt-1 in PC12 cells results in modulation of plakoglobin and E-cadherin and increased cellular adhesion. J Cell Biol (1993) 2.95
Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest (1992) 1.77
The desmosome and pemphigus. Histochem Cell Biol (2008) 1.54
Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies. J Invest Dermatol (2007) 1.45
The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J Exp Med (2003) 1.42
Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J Clin Invest (1988) 1.37
Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. J Clin Invest (1989) 1.26
The tumor-suppressor function of E-cadherin. Am J Hum Genet (1998) 1.25
Exfoliative toxins of Staphylococcus aureus. Toxins (Basel) (2010) 1.12
Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med (2007) 1.10
Antibodies to the desmoglein 1 precursor proprotein but not to the mature cell surface protein cloned from individuals without pemphigus. J Immunol (2009) 0.99
Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin. Am J Pathol (2008) 0.96
Autoantibodies against adhesion molecules and structures in blistering skin diseases. J Exp Med (1995) 0.93
Immunoblot analyses of Brazilian pemphigus foliaceus antigen using different antigen sources. Arch Dermatol Res (1990) 0.86
p38 MAPK Signaling in Pemphigus: Implications for Skin Autoimmunity. Autoimmune Dis (2013) 0.81
Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy. Toxins (Basel) (2016) 0.81
Comparative study of indirect immunofluorescence and immunoblotting for the diagnosis of autoimmune pemphigus. Arch Dermatol Res (1994) 0.80
Characterization of keratocalmin, a calmodulin-binding protein from human epidermis. J Clin Invest (1991) 0.79
Apoptotic pathways in pemphigus. Dermatol Res Pract (2010) 0.79
The Thomsen-Friedenreich antigen-binding lectin jacalin interacts with desmoglein-1 and abrogates the pathogenicity of pemphigus foliaceus autoantibodies in vivo. J Invest Dermatol (2010) 0.75
Rituximab therapy in pemphigus and other autoantibody-mediated diseases. F1000Res (2017) 0.75
Calcium regulation of cell-cell contact and differentiation of epidermal cells in culture. An ultrastructural study. Exp Cell Res (1983) 2.43
Identification of desmosomal surface components (desmocollins) and inhibition of desmosome formation by specific Fab'. J Cell Sci (1984) 2.08
Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest (1984) 1.92
Intermediate filaments and the initiation of desmosome assembly. J Cell Biol (1985) 1.84
Human autoantibodies against a desmosomal core protein in pemphigus foliaceus. J Exp Med (1984) 1.67
Identification and partial characterization of pemphigoid antigen extracted from normal human skin. J Invest Dermatol (1984) 1.61
Immunological comparison of desmosomal components from several bovine tissues. J Cell Biochem (1984) 1.46
Desmosomal proteins: new markers for identification and classification of tumors. Lab Invest (1986) 1.37
Antigenic specificity of fogo selvagem autoantibodies is similar to North American pemphigus foliaceus and distinct from pemphigus vulgaris autoantibodies. J Invest Dermatol (1986) 1.34
Desmocalmin: a calmodulin-binding high molecular weight protein isolated from desmosomes. J Cell Biol (1985) 1.32
Human autoantibodies against desmosomes: possible causative factors in pemphigus. Proc Natl Acad Sci U S A (1984) 1.19
Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell (1991) 3.42
Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell (1981) 2.72
Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature (1993) 2.68
Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med (2000) 2.68
A survey of transformation markers in differentiating epidermal cell lines in culture. Cancer Res (1980) 2.53
Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med (1990) 2.49
Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol (1997) 2.23
Pemphigus: is there another half of the story? J Invest Dermatol (2001) 2.22
Recurrence of pemphigus vulgaris associated with interleukin 2 therapy. Arch Dermatol (1994) 2.03
Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. J Biol Chem (1984) 1.96
Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest (1984) 1.92
Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest (1982) 1.90
Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest (1999) 1.87
Desmoglein 3 anchors telogen hair in the follicle. J Cell Sci (1998) 1.77
Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest (1992) 1.77
Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris. N Engl J Med (1989) 1.72
Human autoantibodies against a desmosomal core protein in pemphigus foliaceus. J Exp Med (1984) 1.67
Nomenclature of the desmosomal cadherins. J Cell Biol (1993) 1.65
Identification and partial characterization of pemphigoid antigen extracted from normal human skin. J Invest Dermatol (1984) 1.61
Protection against pemphigus foliaceus by desmoglein 3 in neonates. N Engl J Med (2000) 1.43
Comparative structural analysis of desmoplakin, bullous pemphigoid antigen and plectin: members of a new gene family involved in organization of intermediate filaments. Int J Biol Macromol (1992) 1.40
Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J Clin Invest (1988) 1.37
Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol (1996) 1.36
Comparison of molecularly cloned bullous pemphigoid antigen to desmoplakin I confirms that they define a new family of cell adhesion junction plaque proteins. J Biol Chem (1991) 1.35
A 230-kD basic protein is the major bullous pemphigoid antigen. J Invest Dermatol (1989) 1.34
Antigenic specificity of fogo selvagem autoantibodies is similar to North American pemphigus foliaceus and distinct from pemphigus vulgaris autoantibodies. J Invest Dermatol (1986) 1.34
The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol (1998) 1.30
Specific epidermal protein markers are modulated during calcium-induced terminal differentiation. J Cell Biol (1983) 1.24
Production of rabbit antibodies against carboxy-terminal epitopes encoded by bullous pemphigoid cDNA. J Invest Dermatol (1990) 1.24
Epidermal cell culture. Transplant Proc (1980) 1.24
A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus. J Immunol (1986) 1.22
Desmoglein isoform distribution affects stratum corneum structure and function. J Cell Biol (2001) 1.21
Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin. J Virol (2001) 1.18
Detection of basement membrane zone antigens during epidermal wound healing in pigs. J Invest Dermatol (1981) 1.16
Epidermolysis bullosa acquisita antigen is synthesized by both human keratinocytes and human dermal fibroblasts. J Invest Dermatol (1985) 1.12
Therapy of pemphigus vulgaris. Arch Dermatol (1999) 1.11
Pemphigus--diseases of antidesmosomal autoimmunity. JAMA (1999) 1.10
The epidermal cell which selectively adheres to a collagen substrate is the basal cell. J Invest Dermatol (1980) 1.08
Pemphigus sera recognize conformationally sensitive epitopes in the amino-terminal region of desmoglein-1. J Invest Dermatol (1995) 1.08
The tumor promoter, 12-O-tetradecanoylphorbol-13-acetate accelerates keratinocyte differentiation and stimulates growth of an unidentified cell type in cultured human epidermis. Exp Cell Res (1982) 1.07
Extracellular domain of pemphigus vulgaris antigen (desmoglein 3) mediates weak homophilic adhesion. J Invest Dermatol (1994) 1.07
Laminin and bullous pemphigoid antigen are distinct basement membrane proteins synthesized by epidermal cells. J Invest Dermatol (1982) 1.06
Ethical accusations: the loss of common sense. Arch Dermatol (2000) 1.05
Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes. J Cell Biol (1993) 1.04
Response to injury of skin involved and uninvolved with psoriasis, and its relation to disease activity: Koebner and 'reverse' Koebner reactions. Br J Dermatol (1982) 1.03
Detection of pemphigoid antigen, pemphigus antigen, and keratin filaments by indirect immunofluorescence in cultured human epidermal cells. J Invest Dermatol (1980) 1.03
Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women. Diabetologia (2008) 1.00
Retinoic acid delays the terminal differentiation of keratinocytes in suspension culture. J Invest Dermatol (1981) 1.00
Squamous epithelial proliferation induced by walleye dermal sarcoma retrovirus cyclin in transgenic mice. Proc Natl Acad Sci U S A (2000) 0.99
Structure and function of basement membrane. J Invest Dermatol (1982) 0.98
Plakoglobin binding by human Dsg3 (pemphigus vulgaris antigen) in keratinocytes requires the cadherin-like intracytoplasmic segment. J Invest Dermatol (1995) 0.97
Translocation of the zinc finger protein basonuclin from the mouse germ cell nucleus to the midpiece of the spermatozoon during spermiogenesis. Biol Reprod (1998) 0.95
A specific antigen-antibody interaction triggers the cellular pathophysiology of bullous pemphigoid. Br J Dermatol (1985) 0.94
The effect of retinoic acid on the expression of pemphigus and pemphigoid antigens in cultured human keratinocytes. J Invest Dermatol (1984) 0.93
Effectiveness of prostaglandin E2 intracervical gel (Prepidil), with immediate oxytocin, versus vaginal insert (Cervidil) for induction of labor. Am J Obstet Gynecol (1998) 0.93
Immunomorphologic and biochemical identification of the pemphigus foliaceous autoantigen within desmosomes. J Invest Dermatol (1992) 0.92
Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice. J Invest Dermatol (1999) 0.91
The use of cDNA clones and monospecific antibodies as probes to monitor keratin gene expression. Ann N Y Acad Sci (1985) 0.90
Central role of the plakoglobin-binding domain for desmoglein 3 incorporation into desmosomes. J Invest Dermatol (2001) 0.90
The baboon as a nonhuman primate model for assessing the effects of maternal immunization with Haemophilus influenzae type b polysaccharide vaccines. Infect Immun (1997) 0.89
Fetal immunization of baboons induces a fetal-specific antibody response. Nat Med (1999) 0.87
Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens. J Invest Dermatol (1990) 0.86
Pemphigus vulgaris antigen lacks biochemical properties characteristic of classical cadherins. J Invest Dermatol (1994) 0.85
Human dermal fibroblasts synthesize laminin. J Invest Dermatol (1988) 0.85
Southern analysis of the 230-kD bullous pemphigoid antigen gene in normal humans, animals, and patients with junctional epidermolysis bullosa. J Invest Dermatol (1991) 0.84
Identification of filaggrin in cultured mouse keratinocytes and its regulation by calcium. J Invest Dermatol (1983) 0.83
Indications for labor induction. Differences between university and community hospitals. J Reprod Med (2000) 0.83
Severe infantile epidermolysis bullosa simplex. Dowling-Meara type. Arch Dermatol (1986) 0.83
Extracellular domain of pemphigus vulgaris antigen (desmoglein 3) mediates weak homophilic adhesion. J Invest Dermatol (1994) 0.83
Effects of intracervical prostaglandin E2 on fetal heart rate and uterine activity patterns in the presence of oligohydramnios. Am J Obstet Gynecol (1995) 0.83
Intracellular domain of desmoglein 3 (pemphigus vulgaris antigen) confers adhesive function on the extracellular domain of E-cadherin without binding catenins. J Cell Biol (1995) 0.82
Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. J Invest Dermatol (1991) 0.82
A unique epithelial basement membrane antigen defined by a monoclonal antibody (KF-1). J Invest Dermatol (1983) 0.82
Postnatal lethality of P-cadherin/desmoglein 3 double knockout mice: demonstration of a cooperative effect of these cell adhesion molecules in tissue homeostasis of stratified squamous epithelia. J Invest Dermatol (2000) 0.82
A specific antigenic defect of the basement membrane is found in basal cell carcinoma but not in other epidermal tumors. Cancer (1982) 0.82
Down syndrome with pure partial trisomy 21q22 due to a paternal insertion (4;21) uncovered by uncultured amniotic fluid interphase FISH. Am J Med Genet A (2005) 0.81
Early postpartum discharge at a university hospital. Outcome analysis. J Reprod Med (2001) 0.80
Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen. Arch Dermatol (1991) 0.79
Intraepidermal neutrophilic IgA/IgG antidesmocollin 1 pemphigus. Br J Dermatol (2006) 0.78
Indirect immunofluorescent localization of benzo[a]pyrene adducted to nucleic acids in cultured mouse keratinocyte nuclei. Carcinogenesis (1982) 0.78
Description of ciliary body anatomy and identification of sites for transscleral cyclophotocoagulation in the equine eye. Vet Ophthalmol (2001) 0.78
Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes. BJOG (2012) 0.77
Maternal pemphigus foliaceus with cell surface antibody bound in neonatal epidermis. Arch Dermatol (1988) 0.77
Pemphigus foliaceus antibodies and a monoclonal antibody to desmoglein I demonstrate stratified squamous epithelial-specific epitopes of desmosomes. Am J Dermatopathol (1987) 0.77
Pemphigus vulgaris antigen is a desmosomal desmoglein. Dermatology (1994) 0.77
Successful management of myocardial infarction during pregnancy in a renal transplant recipient. Clin Cardiol (1998) 0.77
Periconceptional folate intake and neural tube defects. J Am Coll Nutr (1996) 0.77
Epidermal autoantibodies in erythema multiforme. J Am Acad Dermatol (1989) 0.77
Comparative study of bullous pemphigoid antigens among Japanese, British, and U.S. patients indicates similar antigen profiles with the 170-kD antigen present both in the basement membrane and on the keratinocyte cell membrane. J Invest Dermatol (1993) 0.76
The histologic reliability of laser cone biopsy of the cervix. Obstet Gynecol (1991) 0.75
Understanding of the pathophysiology of pemphigus suggests innovative therapeutic approaches. Br J Dermatol (2000) 0.75
Clinical, histologic, and immunopathologic comparison of pemphigus vulgaris and pemphigus foliaceus. Semin Dermatol (1988) 0.75
A statewide, toll-free telephone service to improve obstetric care. J Okla State Med Assoc (1995) 0.75
Cloning of the 5' mRNA for the 230-kD bullous pemphigoid antigen by rapid amplification of cDNA ends. J Invest Dermatol (1993) 0.75
Should you throw away this issue? Arch Dermatol (1993) 0.75
IgA immune complexes in patients with dermatitis herpetiformis occur in the absence of IgA rheumatoid factor. J Invest Dermatol (1987) 0.75
Erythema annulare-like acantholytic dermatosis (EAAD): nonbullous pemphigus or a new entity? Am J Med Sci (1993) 0.75